Form D · Other Health Care

ColubrisMX, Inc.

Houston, TX · CIK 0001694306

Offering snapshot reported Jun 2, 2021 · SEC filing

Reported sold: $76.1M
Investors reported: 7
Minimum accepted: $0
First sale: Apr 16, 2021

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$68,993,973 → $76,076,973

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jun 2, 2021	Amendment	$76,076,973	$7,083,000vs May 3, 2021	7	SEC filing
May 3, 2021	Initial	$68,993,973	No comparison	7	SEC filing
Jan 3, 2019	Initial	$3,999,998	No comparison	3	SEC filing
Mar 8, 2017	Initial	$10,666,666	No comparison	5	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $3.2M (estimated)
Finders' fees: $0
Form D file number: 021-397911

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
GT Securities, Inc.	116012

Source: Form D, filed Jun 2, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Neeraj Agrawal	Director
Kurt Azarbarzin	Director, Executive
Eduardo Ramon Alejandro Fonseca Ward	Director
Daniel H. Kim	Director, Executive
Daniel Kim, Md	Director, Executive
Cary Mc Nair	Director
R. Cary Mc Nair, Jr.	Director
Daniel Wolterman	Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:

327 Terrace Drive
Houston, TX, 77007